Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | FORM 4 | 17 Jan 2025 |
| Alight, Inc. / Delaware | FORM 4 | 17 Jan 2025 |
| Alight, Inc. / Delaware | FORM 4 | 17 Jan 2025 |
| Alight, Inc. / Delaware | FORM 4 | 17 Jan 2025 |
| Alight, Inc. / Delaware | FORM 4 | 17 Jan 2025 |
| Hagerty, Inc. | FORM 4 | 17 Jan 2025 |
| AIM ImmunoTech Inc. | 4 | 17 Jan 2025 |
| AIM ImmunoTech Inc. | 4 | 17 Jan 2025 |
| Triller Group Inc. | 4 | 17 Jan 2025 |
| Spyre Therapeutics, Inc. | FORM 4 | 17 Jan 2025 |
| Spyre Therapeutics, Inc. | FORM 4 | 17 Jan 2025 |
| Spyre Therapeutics, Inc. | FORM 4 | 17 Jan 2025 |
| Spyre Therapeutics, Inc. | FORM 4 | 17 Jan 2025 |
| Adaptimmune Therapeutics PLC | OWNERSHIP DOCUMENT | 17 Jan 2025 |
